Selective Estrogen Receptor Modulators (SERMs)
13 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

A premenopausal client is prescribed raloxifene for breast cancer prevention. What potential side effect should the nurse include in the client's education?

  • Weight gain
  • Increased appetite
  • Hot flashes (correct)
  • Decreased libido

A client taking raloxifene reports sudden onset chest pain and difficulty breathing. What is the priority nursing action?

  • Notify the primary care provider immediately. (correct)
  • Administer oxygen and monitor vital signs.
  • Reassure the client and assess pain level.
  • Instruct the client to perform deep breathing exercises.

Which condition would be a contraindication for a client considering raloxifene therapy?

  • Osteoporosis
  • Elevated serum lipid levels
  • History of deep vein thrombosis (correct)
  • Family history of breast cancer

A client who is on raloxifene develops a deep vein thrombosis. What is the most appropriate action?

<p>Consult the provider about discontinuing the medication. (A)</p> Signup and view all the answers

Why is concurrent administration of raloxifene and estrogen not recommended?

<p>Increases the risk for estrogen-supported cancers. (A)</p> Signup and view all the answers

Why is raloxifene generally preferred over tamoxifen by primary care providers for postmenopausal women?

<p>Raloxifene carries a lower risk of uterine cancer. (B)</p> Signup and view all the answers

A postmenopausal woman is prescribed raloxifene. Which instruction should the nurse emphasize regarding lifestyle modifications?

<p>Engage in daily weight-bearing exercises and ensure adequate calcium and vitamin D intake. (C)</p> Signup and view all the answers

A client taking raloxifene reports sudden onset of shortness of breath and chest pain. What is the priority nursing intervention?

<p>Administer oxygen and notify the healthcare provider immediately. (D)</p> Signup and view all the answers

Raloxifene's mechanism of action involves:

<p>Selectively activating estrogen receptors in bone tissue while blocking them in breast tissue. (B)</p> Signup and view all the answers

Which of the following findings would warrant immediate discontinuation of raloxifene?

<p>Leg pain and swelling in one leg. (A)</p> Signup and view all the answers

A patient with a history of deep vein thrombosis (DVT) is asking about options for managing her osteoporosis. What information is most important to consider?

<p>Raloxifene may increase the risk of thromboembolic events and should be used cautiously or avoided in patients with a history of DVT. (B)</p> Signup and view all the answers

A client of childbearing age is prescribed raloxifene. What is the most important instruction to provide regarding pregnancy?

<p>Raloxifene is teratogenic and should not be taken during pregnancy. (C)</p> Signup and view all the answers

Which laboratory value is most important to monitor in a client receiving raloxifene therapy?

<p>Bone mineral density (BMD) (A)</p> Signup and view all the answers

Flashcards

Raloxifene Side Effect

Hot flashes can be a side effect of raloxifene in premenopausal women.

SERM Blood Clot Risk

Report leg or chest pain with breathing difficulty immediately; could indicate a blood clot.

SERMs and Pregnancy

SERMs are unsafe during pregnancy and breastfeeding due to teratogenic effects.

SERMs and DVT History

A history of DVT is a contraindication for SERM use.

Signup and view all the flashcards

SERMs and Estrogen

Avoid using SERMs concurrently with estrogen due to increased cancer risk.

Signup and view all the flashcards

SERMs

Medications that activate estrogen receptors in some tissues and block them in others.

Signup and view all the flashcards

Primary therapeutic uses of SERMs

Prevention and treatment of postmenopausal osteoporosis and for clients at risk for or have had treatment for estrogen-dependent cancer.

Signup and view all the flashcards

Prototype SERM

Raloxifene.

Signup and view all the flashcards

Pharmacologic Action of SERMs

Decreases bone resorption and bone loss, maintaining bone mineral density (BMD).

Signup and view all the flashcards

Serious Adverse Effects of Raloxifene

Increased risk of stroke, pulmonary embolism, and deep vein thrombosis.

Signup and view all the flashcards

SERMs and Pregnancy/Breastfeeding

Not for pregnant or breastfeeding clients.

Signup and view all the flashcards

Nursing Interventions for SERMs

Monitor bone density, observe for blood clots, and monitor lab results.

Signup and view all the flashcards

Client Instructions for SERMs

Consume adequate calcium and vitamin D, perform weight-bearing exercises, and use contraception during therapy.

Signup and view all the flashcards

Study Notes

  • Selective Estrogen Receptor Modulators (SERMs) are mainly used for preventing and treating postmenopausal osteoporosis.
  • SERMs are suitable for clients at risk of or previously treated for estrogen-dependent or receptor-positive cancer.

Prototype and Other Medications

  • Raloxifene serves as the prototype medication for SERMs.
  • Raloxifene is more commonly prescribed than tamoxifen due to its lower risk of uterine cancer.
  • Medication classification: Bone Resorption Inhibitor.

Pharmacologic Action

  • SERMs activate estrogen receptors in some tissues while blocking them in others.
  • This action reduces bone resorption and bone loss, maintaining bone mineral density (BMD).
  • Raloxifene blocks estrogen receptors in breast tissue, beneficial for clients with estrogen-dependent or positive cancer.
  • Unlike most SERMs, raloxifene does not activate receptors in the endometrium.

Adverse Drug Reactions

  • Adverse reactions primarily relate to the activation of estrogen receptors.
  • Serious adverse effects of raloxifene include increased risk of stroke, pulmonary embolism, and deep vein thrombosis.
  • Hot flashes may occur due to the blockage of estrogen receptors in other tissues.

Safety Information

  • SERMs are teratogenic and should not be taken during pregnancy or breastfeeding.
  • SERMs can pass through breast milk, potentially harming the infant.

Interventions

  • Monitor bone density to assess the effectiveness of SERM therapy.
  • Watch for signs of blood clots in the lower legs or lungs, such as leg cramps and difficulty breathing.
  • Routine lab work is important to monitor blood components like cholesterol, hormones, and fibrinogen.

Administration

  • SERMs are administered orally on a daily basis.
  • Can be taken with or without food.

Client Instructions

  • Consume enough calcium and vitamin D.
  • Engage in daily weight-bearing exercises like walking or running.
  • Use contraception to prevent pregnancy during therapy.
  • Premenopausal clients using raloxifene for breast cancer prevention may experience hot flashes.

Safety Alert

  • Clients should immediately report pain in the lower extremities or chest pain with difficulty breathing.
  • These symptoms may indicate a blood clot in the leg or lungs.

Contraindications and Precautions

  • Raloxifene and tamoxifen are contraindicated in pregnant and breastfeeding clients due to teratogenic effects.
  • Clients with deep vein thrombosis or a history of it should not take SERMs.
  • Discontinue SERMs if deep vein thrombosis develops during treatment.
  • Use SERMs with caution in clients with elevated serum lipid levels.

Interactions

  • Concurrent administration with estrogen is not recommended due to the increased risk of estrogen-supported cancers.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

Selective Estrogen Receptor Modulators (SERMs) like Raloxifene, prevent osteoporosis by modulating estrogen receptors. Raloxifene, a bone resorption inhibitor, is favored over tamoxifen because it doesn't activate receptors in the endometrium, reducing the risk of uterine cancer. It blocks estrogen receptors in breast tissue, which benefits clients with estrogen-dependent or positive cancer.

More Like This

Raloxifene (Evista) Flashcards
15 questions
Raloxifene (Evista) Flashcards
10 questions
Raloxifene Drug Overview
13 questions
Use Quizgecko on...
Browser
Browser